Oxaliplatin-Based Adjuvant Chemotherapy for Stage III Colon Cancer
This phase 3 randomized clinical trial evaluates the outcomes and the incidence of peripheral sensory neuropathy of 3 months vs 6 months of adjuvant oxaliplatin-based chemotherapy for colon cancer.